A substance intended to be used to decrease platelet function in a whole blood specimen by inhibiting platelet activation and/or aggregation in preparation for subsequent analysis. It typically contains a platelet activation and/or aggregation inhibitor (e.g., abciximab), buffers and stabilizers.